CURIT Biotech Holding holds shares in several companies and projects that develop and market therapeutics and diagnostics for cancer, chronic inflammation and other auto immune diseases.

This particularly includes projects in the field of medical biotechnology as one of the worldwide markets of the future:

• Development of a biochip reader with cartridges for quick diagnostic of cancer and auto immune diseases
• Production and Distribution of antibody-based fusion proteins
• Production and Distribution of antibodies conjugated to nanoparticles

We will be happy to provide more information on our projects. Simply get in touch with us!